Effects of Nasal High Flow Therapy on Ventilation and Gas Exchange in Healthy Newborns

NCT02632825 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-10-31

No results posted yet for this study

Summary

Nasal High Flow (NHF) and CPAP are established forms of respiratory support in neonates and often produce similar clinical outcomes. It has been shown in adults that NHF produce different effects on ventilation during wakefulness and sleep. There is no physiological data on effects of NHF in neonates. The physiological effects may be impacted by sleep/awake status.

Conditions

  • Respiratory Support

Interventions

DEVICE

Nasal High Flow

Nasal High Flow Therapy

Sponsors & Collaborators

  • Fisher and Paykel Healthcare

    collaborator INDUSTRY
  • Research Center of Maternal and Child Health Protection, Armenia

    lead OTHER

Principal Investigators

  • Pavel Mazmanyan, MD, PhD · Head of Neonatal Unit of Research Centre of Maternal and Child Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
1 Day
Max Age
3 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-04-30
Completion
2016-05-31

Countries

  • Armenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02632825 on ClinicalTrials.gov